Very apt thread for the company "the future". I think the future is bright for the shareholders as well as for the osteoarthritis patients. I dare say this coz we have got The Product and the men to market it. Now that's the combination which is hard to beat. Recently A2, APT and in our very own space CUV showed what the above combination can achieve interms of SP.
just read in stock head Mr. Rennie said that he was approached by some big pharmas for the deal but paradigm decided to take the unconventional path instead of going with the deal they decided to capital raise. Morgan's dint seem to be impressed hence they reduced the price target to 1.77......... as far as iam concerned it takes courage, confident in the product they have and above all strategy that our management team has that getting the product as close to making it commercial will fetch bigger bank for the buck. IMO this is the master stroke by the management. Deal made now may fetch us in millions as suppose to a deal made one year down the line with phase 3 trial confirmed may well fetch us in billion hence why it's a risky but a smart and confident move by the management
all I want to do is sit back and let this paradigm box unfold for at least 1year and let the goodies keep coming one by one in the process. Don't let daily sp worry me much.
as always please do your own reseahttps://**promotion blocked**/health/health-paradigm-in-no-rush-to-partner-with-big-pharma-for-its-knee-pain-drug/rch
the above is my humble opinion only
SS
- Forums
- ASX - By Stock
- PAR
- The Future
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
2.20%
!
46.5¢

The Future, page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
46.5¢ |
Change
0.010(2.20%) |
Mkt cap ! $184.8M |
Open | High | Low | Value | Volume |
45.5¢ | 48.0¢ | 44.0¢ | $534.2K | 1.168M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5245 | 45.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
47.0¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 23000 | 0.450 |
1 | 10000 | 0.440 |
1 | 23255 | 0.430 |
2 | 45000 | 0.425 |
2 | 21531 | 0.415 |
Price($) | Vol. | No. |
---|---|---|
0.470 | 10000 | 1 |
0.475 | 13560 | 2 |
0.480 | 90598 | 3 |
0.485 | 10000 | 1 |
0.490 | 18000 | 2 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online